J2 Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
13,782
+99
| +0.7% | +$3.8K | 0.42% | 58 |
|
|
2025
Q1 | $530K | Sell |
13,683
-3,930
| -22% | -$152K | 0.49% | 36 |
|
|
2024
Q4 | $596K | Buy |
+17,613
| New | +$596K | 0.56% | 35 |
|
|
2023
Q3 | $604K | Buy |
16,662
+26
| +0.2% | +$943 | 0.76% | 27 |
|
|
2023
Q2 | $593K | Buy |
16,636
+1,548
| +10% | +$55.2K | 0.7% | 33 |
|
|
2023
Q1 | $537K | Buy |
15,088
+521
| +4% | +$18.5K | 0.83% | 27 |
|
|
2022
Q4 | $512K | Buy |
14,567
+558
| +4% | +$19.6K | 0.88% | 22 |
|
|
2022
Q3 | $412K | Buy |
14,009
+9,251
| +194% | +$272K | 0.78% | 23 |
|
|
2022
Q2 | $259K | Sell |
4,758
-1,508
| -24% | -$82.1K | 0.39% | 61 |
|
|
2022
Q1 | $341K | Sell |
6,266
-721
| -10% | -$39.2K | 0.37% | 56 |
|
|
2021
Q4 | $385K | Buy |
+6,987
| New | +$385K | 0.37% | 44 |
|